๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Continuous systemic 5-fluorouracil infusion in refractory prostatic cancer

โœ Scribed by R. Hansen; T. Moynihan; P. Beatty; E. Quebbeman; J. Libnoch; W. Schulte; T. Anderson


Book ID
119046920
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
483 KB
Volume
37
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Continuous systemic 5-fluorouracil infus
โœ R. Hansen; E. Quebbeman; R. Ausman; J. Frick; P. Ritch; W. Schulte; C. Haas; P. ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 411 KB

Ninety-one patients with metastatic colorectal cancer were treated with continuous ambulatory 5-fluorouracil(5FU) infusion 250-300 mg/m2/day through a chronic indwelling central venous catheter. Twenty-six of the 91 patients (29%) had received previous bolus 5FU. Fifty-eight of the 91 patients (64%)

5-fluorouracil rechallenge by protracted
โœ Khaled Jabboury; Frankie Ann Holmes; Gabriel Hortobagyi ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 489 KB ๐Ÿ‘ 1 views

The authors assessed the value of protracted low-dose 5-fluorouracil (5-FU) infusion (250 mg/m\*/day) in refractory breast cancer. Thirty-six patients with prior 5-FU exposure who were not eligible for other investigational therapeutic measures mainly due to extensive prior chemotherapy (median, fou